India, March 25 -- Illumina, Inc. (ILMN), an American biotechnology company, Tuesday has announced changes to its Board of Directors. Scott Gottlieb, MD, who has been a board member since 2020, has been elected as the non-executive Chair.
Additionally, Keith Meister, the founder, Managing Partner, and Chief Investment Officer of Corvex Management, will join the board on March 28, 2025. Meanwhile, Stephen MacMillan, Chairman, President, and CEO of Hologic, who joined Illumina's Board in June 2023, will step down ahead of the company's upcoming annual shareholders' meeting.
Dr. Gottlieb expressed appreciation for Illumina's impact on genomics and emphasized his commitment to collaborating with the board and management team to drive innovati...